111 related articles for article (PubMed ID: 19025883)
1. Tumor imaging using P866, a high-relaxivity gadolinium chelate designed for folate receptor targeting.
Corot C; Robert P; Lancelot E; Prigent P; Ballet S; Guilbert I; Raynaud JS; Raynal I; Port M
Magn Reson Med; 2008 Dec; 60(6):1337-46. PubMed ID: 19025883
[TBL] [Abstract][Full Text] [Related]
2. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
Müller C; Forrer F; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Feb; 49(2):310-7. PubMed ID: 18199624
[TBL] [Abstract][Full Text] [Related]
3. MR imaging of ovarian tumors using folate-receptor-targeted contrast agents.
Wang ZJ; Boddington S; Wendland M; Meier R; Corot C; Daldrup-Link H
Pediatr Radiol; 2008 May; 38(5):529-37. PubMed ID: 18357444
[TBL] [Abstract][Full Text] [Related]
4. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
5. 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation.
Rossin R; Pan D; Qi K; Turner JL; Sun X; Wooley KL; Welch MJ
J Nucl Med; 2005 Jul; 46(7):1210-8. PubMed ID: 16000291
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99mTc-radiofolate tracer.
Müller C; Schubiger PA; Schibli R
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1162-70. PubMed ID: 16721570
[TBL] [Abstract][Full Text] [Related]
7. Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo.
Müller C; Brühlmeier M; Schubiger PA; Schibli R
J Nucl Med; 2006 Dec; 47(12):2057-64. PubMed ID: 17138750
[TBL] [Abstract][Full Text] [Related]
8. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
Choi H; Choi SR; Zhou R; Kung HF; Chen IW
Acad Radiol; 2004 Sep; 11(9):996-1004. PubMed ID: 15350580
[TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced folate-receptor-targeted MR imaging using a Gd-loaded PEG-dendrimer-folate conjugate in a mouse xenograft tumor model.
Chen WT; Thirumalai D; Shih TT; Chen RC; Tu SY; Lin CI; Yang PC
Mol Imaging Biol; 2010 Apr; 12(2):145-54. PubMed ID: 19636639
[TBL] [Abstract][Full Text] [Related]
11. MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent.
Saborowski O; Simon GH; Raatschen HJ; Wendland MF; Fu Y; Henning T; Baehner R; Corot C; Chen MH; Daldrup-Link HE
Contrast Media Mol Imaging; 2007; 2(2):72-81. PubMed ID: 17385788
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts.
Konda SD; Wang S; Brechbiel M; Wiener EC
Invest Radiol; 2002 Apr; 37(4):199-204. PubMed ID: 11923642
[TBL] [Abstract][Full Text] [Related]
13. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate.
Mathias CJ; Wang S; Lee RJ; Waters DJ; Low PS; Green MA
J Nucl Med; 1996 Jun; 37(6):1003-8. PubMed ID: 8683292
[TBL] [Abstract][Full Text] [Related]
14. Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent.
Stefflova K; Li H; Chen J; Zheng G
Bioconjug Chem; 2007; 18(2):379-88. PubMed ID: 17298029
[TBL] [Abstract][Full Text] [Related]
15. Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells.
Setua S; Menon D; Asok A; Nair S; Koyakutty M
Biomaterials; 2010 Feb; 31(4):714-29. PubMed ID: 19822364
[TBL] [Abstract][Full Text] [Related]
16. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor.
Wiener EC; Konda S; Shadron A; Brechbiel M; Gansow O
Invest Radiol; 1997 Dec; 32(12):748-54. PubMed ID: 9406015
[TBL] [Abstract][Full Text] [Related]
17. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
19. Oligoethylenimine-grafted chitosan as enhanced T1 contrast agent for in vivo targeted tumor MRI.
Tong X; Liu M; Zhang K; Cao Y; Dong J; Jiang B; Lu B; Zheng H; Zhang H; Pei R
J Magn Reson Imaging; 2016 Jul; 44(1):23-9. PubMed ID: 26713668
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
